Human factor in the use of automated insulin delivery systems: Real-world effects in children with type 1 diabetes after 2 years of use (AID-A study)
Authors' conclusion
AID system use is associated with clinically relevant improvements in glycaemic control and decrease in daily diabetes-related burden on affected children and their parents.
Study context
- Population
- Children with T1D using AID systems in a real-world setting
- Participants
- 111 children
- Exposure
- Before vs after 1 and 2 years of AID use
- Outcome
- Glycaemic control
- Follow-up
- 1 year
Main finding
As reported in the abstract
HbA1c decreased (from → to)
8.1 % (65 mmol/mol) to 7.7 % (61 mmol/mol)
TIR increased (from → to)
55 % to 64 %
TBR decreased (from → to)
2.6 % to 1.8 %
GMI improved
7.6 % vs. 7.3 %
Observational data: associations, not effects.
Further findings
Glycaemic control (stabilised) · 2 years
- HbA1c
- 7.6 % [60 mmol/mol]
- TIR
- 62 %
- TBR
- 1.3 %
- GMI
- 7.4 %
Daily life
- Adolescents and parents reported improvements in daily life (sleep, stress, fear of hypoglycaemia)
Safety
- BMI-SDS scores increased in the first year
Original publication
Human factor in the use of automated insulin delivery systems: Real-world effects in children with type 1 diabetes after 2 years of use (AID-A study). Diabetes Res Clin Pract. Published 9 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →